Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
ARWR
Stock Latest News
The Fly
Arrowhead granted breakthrough therapy designation for plozasiran by FDA
10d ago
ARWR
Premium
The Fly
Arrowhead to host conference call
17d ago
ARWR
Premium
The Fly
Arrowhead presents new pivotal Phase 3 data from PALISADE study of Plozasiran
18d ago
ARWR
Premium
The Fly
Arrowhead to advance two RNAi-based obesity candidates into clinical studies
1M ago
ARWR
Premium
The Fly
Arrowhead price target lowered to $28 from $31 at Goldman Sachs
1M ago
ARWR
Premium
The Fly
Arrowhead reports Q3 EPS ($1.38), consensus (55c)
1M ago
ARWR
Premium
The Fly
Arrowhead announces $500M strategic financing with Sixth Street
1M ago
ARWR
Premium
Pre-Earnings
ARWR Upcoming Earnings Report: What to Expect?
1M ago
ARWR
Premium
The Fly
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
2M ago
ALT
PFE
Premium
The Fly
Arrowhead price target lowered to $60 from $90 at H.C. Wainwright
3M ago
ARWR
Premium
The Fly
Arrowhead to advance plozasiran into Phase 3 cardiovascular outcomes trial
3M ago
ARWR
Premium
The Fly
Arrowhead presents preclinical data on new ARO-INHBE
3M ago
ARWR
Premium
The Fly
Ionis Pharmaceuticals upgraded to Market Perform from Underperform at Bernstein
3M ago
ALNY
ARWR
Premium
The Fly
Instacart, Boston Beer upgraded: Wall Street’s top analyst calls
4M ago
HY
COP
Premium
The Fly
Arrowhead initiated with a Neutral at Goldman Sachs
4M ago
ARWR
Premium
The Fly
Arrowhead announces topline results from PALISADE study
4M ago
ARWR
Premium
The Fly
Arrowhead announces results from ARCHES-2 study
4M ago
ARWR
Premium
The Fly
Arrowhead presents new Phase 2 Data of plozasiran in hyperlipidemia
4M ago
ARWR
Premium
The Fly
Arrowhead announces new interim clinical data on ARO-RAGE
4M ago
ARWR
Premium
The Fly
Arrowhead price target lowered to $27 from $36 at Morgan Stanley
4M ago
ARWR
Premium
The Fly
Arrowhead price target lowered to $29 from $34 at Citi
4M ago
ARWR
Premium
The Fly
Arrowhead reports Q2 EPS ($1.02), consensus (16c)
4M ago
ARWR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
